Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Viela Bio, Inc. (VIE)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viela Bio, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Viela Bio, Inc. since 2005.
The reporting company's ticker symbol is VIE. The reporting company's CIK number is 1734517.
The total value of stock buying since 2005 is $24,062,722.
The total value of stock sales since 2005 is $800,498.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-08||Tong Xiaomeng (Director)||Buy||36,091||21.83||787,722|
|2019-10-07||Tong Xiaomeng (Director)||Buy||300,000||19.00||5,700,000|
|2019-10-07||Tong Xiaomeng (Director)||Sale||36,091||22.18||800,498|
|2019-10-07||Wicki Andreas (Director)||Buy||500,000||19.00||9,500,000|
|2019-10-07||Astrazeneca Uk Ltd (10% Owner)||Buy||425,000||19.00||8,075,000|
Insider trading activities including stock purchases, stock sales, and option exercises of VIE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viela Bio, Inc. (symbol VIE, CIK number 1734517) see the Securities and Exchange Commission (SEC) website.